Tenaya Therapeutics (TNYA) Non-Current Assets (2020 - 2026)

Tenaya Therapeutics' Non-Current Assets history runs 7 years deep, the most recent figure standing at $38.5 million for Q1 2026.

• On a quarterly basis, Non-Current Assets fell 22.15% year-over-year to $38.5 million in Q1 2026; TTM through Mar 2026 was $169.9 million, a 21.16% decrease from a year earlier, with the FY2025 full-year figure at $41.3 million, down 21.36% from the prior year.
• Non-Current Assets eased to $38.5 million in Q1 2026 per TNYA's latest filing, from $41.3 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $90.7 million in Q1 2023 and bottomed at $38.5 million in Q1 2026.
• The 5-year median for Non-Current Assets is $58.2 million (2024), against an average of $60.7 million.
• Across the five-year window, Non-Current Assets surged 60.82% in 2022 and slumped 38.05% in 2024, its largest moves.
• Year by year, Non-Current Assets stood at $85.2 million in 2022, then slumped by 30.82% to $58.9 million in 2023, then slipped by 10.81% to $52.6 million in 2024, then decreased by 21.36% to $41.3 million in 2025, then dropped by 6.84% to $38.5 million in 2026.
• Per Business Quant, the three latest TNYA Non-Current Assets figures stand at $38.5 million (Q1 2026), $41.3 million (Q4 2025), and $43.7 million (Q3 2025).